Current Report Filing (8-k)
December 02 2022 - 5:06AM
Edgar (US Regulatory)
0001497130
false
0001497130
2022-11-02
2022-11-02
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): November
2, 2022
NANO
MOBILE HEALTHCARE, INC.
(Exact
Name of Registrant as Specified in its Charter)
Nevada (State
or other jurisdiction of incorporation) |
000-55155 (Commission File
Number) |
98-0659770 (I.R.S.
Employer Identification No.) |
370
Ampola Ave., Suite 200-A
Torrance, CA 90501
(Address of Principal Executive Offices and Zip Code)
Registrant’s
telephone number, including area code: (424) 358-1046
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
Trading
Symbol(s) |
Name
of each exchange on which registered |
Common
Stock, par value of $0.00001 |
VNTH |
OTCMKTS |
Item
4.01 |
Changes
in Registrant’s Certifying Accountant |
On
November 2, 2022 the Registrant engaged Haroon Imtiaz, CPA as the Registrant's new independent registered public accounting firm. The
appointment of Haroon Imtiaz, CPA was approved by the Board of Directors of Nano Mobile Healthcare, Inc.. Haroon Imtiaz, CPAwill be reviewing
and providing audit services related to the financial statements that are to be included in the Annual Report for the period ended December
31, 2021. Haroon Imtiaz, CPA did not prepare or provide any financial reports for any periods prior to the date of engagement, nor did
it prepare or provide any financial reports for, or prior to the year ended December 31, 2021. Neither the Company, nor any person on
behalf of the Company, consulted with Haroon Imtiaz, CPA during the Company's two most recent fiscal years or the subsequent interim
period prior to the engagement of Haroon Imtiaz, CPA.
Item
9.01. Financial Statements and Exhibits.
Exhibit
No.
10.1
Audit Report
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
NANO
MOBILE HEALTHCARE, INC.
Date: December 1, 2022 |
By:
/s/ Adam Matruski |
|
Name: |
Adam Matruski |
|
Title: |
Chairman, President and CEO |
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Sep 2023 to Sep 2024